文献速递慢性肾脏病

慢性肾脏病贫血更新:2018核心教程

Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018.
PubMed 文献 · Am J Kidney Dis · 2018-01-11

本文综述慢性肾脏病(CKD)后期贫血的流行病学、病理生物学、临床评估与治疗。贫血发生与促红细胞生成素相对不足及铁缺乏相关,缺氧感知系统与铁调素介导的炎症性铁利用障碍是新认识的关键机制。

要点

  • CKD后期贫血常见,可致乏力、气短等症状。
  • 促红细胞生成素相对不足是贫血的核心机制。
  • 慢性炎症与铁调素参与铁利用障碍。

核心结论

  • CKD贫血的发病机制复杂,核心为促红细胞生成素相对不足,铁缺乏为第二重要因素。

研究设计与样本

  • 综述,回顾CKD贫血的流行病学、病理生物学、临床评估和治疗。

主要发现

  • 缺氧感知系统在促红细胞生成素合成与释放中起关键作用。
  • 慢性炎症与铁调素是铁利用障碍的重要介导因素。

临床怎么用

  • 临床应关注CKD后期贫血的症状评估,并重视铁缺乏与炎症对铁利用的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Anemia is a frequent complication during the later stages of chronic kidney disease. When present, it may cause symptoms such as fatigue and shortness of breath. The pathogenesis of anemia in chronic kidney disease is complex, but a central feature is a relative deficit of erythropoietin. New information has elucidated the critical role of the hypoxia-sensing system in mediating erythropoietin synthesis and release. Iron deficiency is a second important factor in the anemia of chronic kidney disease. New insights into the dynamics of iron metabolism have clarified the role of chronic inflammation and hepcidin as key mediators of impaired iron utilization. In this article, we review the epidemiology, pathobiology, clinical evaluation, and treatment of anemia in chronic kidney disease.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Fishbane S, Spinowitz B. Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018. Am J Kidney Dis. 2018. PMID: 29336855. doi:10.1053/j.ajkd.2017.09.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。